Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optocell was a German life science tools company focused on monitoring and analytical systems for upstream bioprocessing in the pharma and biotech market. The company supplied at-line bioprocess analysis solutions and emphasized applications across mammalian cell culture, bacterial, yeast, and algae cultivation, along with cell counting technologies based on trypan blue staining and image recognition. Its products appear to have been used in R&D, process development, and production environments rather than in therapeutic drug development as a sponsor. Corporate records indicate the company was in liquidation, suggesting it is no longer an active operating business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optocell.